| COVID-19 | Coronavirus disease 19 |
| HIV | Human immunodeficiency virus |
| NCI | National cancer institute |
| IC50 | Inhibitory concentration |
| ERK | Extracellular signal-regulated protein kinase |
| SD | Standard deviation |
| ROS | Reactive oxygen species |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| Nqo1 | NAD(P)H:quinone dehydrogenase 1 |
| HO-1 | Heme oxygenase 1 |
| GCLC | Glutamate–cysteine ligase catalytic subunit |
| GCLM | Glutamate–cysteine ligase modifier subunit |
| ARE | Antioxidant response element |
| PV-1 | Poliovirus type 1 |
| NDV | Newcastle disease virus |
| HSV-1 | Herpes simplex virus type 1 |
| VV | Vaccinia virus |
| SAR | Structure–activity relationship |
| LMP | Lysosomal membrane permeability |
| RN | Regulated necrosis |
| PI3K | Phosphoinositide 3-kinase |
| mTOR | Mammalian target of rapamycin |
| TMS | Tetramethylsilane |
| ESI-MS | Electrospray ionization mass spectrometry |